Diagnosis and management of adult patients with chronic intestinal pseudoobstruction

Nutrition in Clinical Practice

Volumn 21, Issue 1, 2006, Pages 16-22

  Sutton, Dwight H ^a   Harrell, Steven P ^a   Wo, John M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTIPARKINSON AGENT; BETHANECHOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOLASETRON MESILATE; DOMPERIDONE; ERYTHROMYCIN; GRANISETRON; METOCLOPRAMIDE; NEOSTIGMINE; OCTREOTIDE; ONDANSETRON; OPIATE; PALONOSETRON; PROCHLORPERAZINE; PROKINETIC AGENT; PROMETHAZINE; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; SOMATOSTATIN DERIVATIVE; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMETHOBENZAMIDE;

ANATOMY; CHRONIC INTESTINAL PSEUDOOBSTRUCTION; CLINICAL FEATURE; CLINICAL TRIAL; CONFUSION; DIAGNOSTIC TEST; DROWSINESS; DYSTONIA; ENDOSCOPY; FATIGUE; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRANSIT; HISTOPATHOLOGY; HUMAN; INCIDENCE; INSOMNIA; INTESTINE MOTILITY; INTESTINE PSEUDOOBSTRUCTION; INTESTINE TRANSPLANTATION; NUTRITIONAL SUPPORT; PATHOGENESIS; PATHOPHYSIOLOGY; RARE DISEASE; RESTLESSNESS; REVIEW; SYMPTOM; TARDIVE DYSKINESIA; TREATMENT OUTCOME;

CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; NUTRITIONAL SUPPORT; RADIOGRAPHY, ABDOMINAL;

EID: 31944445332     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/011542650602100116     Document Type: Review

References (40)

1. Dudley HA, Sinclair IS, McLaren IF, McNair TJ, Newsam JE. Intestinal pseudo-obstruction. J Royal Coll Surg Edinb. 1958;3:206-217.
2. Maldonado JE, Gregg JA, Green PA, Brown AL Jr. Chronic idiopathic intestinal pseudo-obstruction. Am J Med. 1970;49:203-212.
3. Rudolph CD, Hyman PE, Altschuler SM, et al. Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Ped Gastroenterol Nutr. 1997;24:102-112.
4. Wood JD, Alpers DH, Andrews PL. Fundamentals of neurogastroenterology. Gut. 1999;45(suppl 2):II6-II16.
5. Fauck DL, Anuras S, Gardner GD, Mitros FA, Summers RW, Christensen J. A familial visceral myopathy. Ann Intern Med. 1978;89:600-606.
6. Schuffler MD, Pope CE. Studies of idiopathic intestinal pseudoobstruction, II: hereditary hollow visceral myopathy: family studies. Gastroenterology. 1977;73:339-344.
7. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999;283:689-692.
8. Levin KH. Paraneoplastic neuromuscular syndromes. Neurol Clin. 1997;15:597-614.
9. Sutton I, Winer JB. The immunopathogenesis of paraneoplastic neurological syndromes. Clin Sci. 2002;102:475-486.
10. Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology. 1998;50:652-657.
11. Lennon VA, Sas DF, Busk MF, et al. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology. 1991;100:137-142.
12. Briellmann RS, Sturzenegger M, Gerber HA, Schaffner T, Hess CW. Autoantibody-associated sensory neuronopathy and intestinal pseudo-obstruction without detectable neoplasia. Eur Neurol. 1996;36:369-373.
13. Lefkowitz JR, Brand DL, Schuffler MD, Brugge WR. Amyloidosis mimics achalasia's effect on lower esophageal sphincter. Dig Dis Sci. 1989;34:630-635.
14. Gilat T, Revach M, Sonar E. Deposition of amyloid in the gastrointestinal tract. Gut. 1969;10:98-104.
15. Tada S, Iida M, Yao T, Kitamoto T, Yao T, Fujishima M. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein. Gut. 1993;34:1412-1417.
16. Nowak TV, Ionasescu V, Anuras S. Gastrointestinal manifestations of the muscular dystrophies. Gastroenterology. 1982;82:800-810.
17. Brunner HG, Hamel BC, Rieu P, Howeler CJ, Peters FT. Intestinal pseudo-obstruction in myotonic dystrophy. J Med Genet. 1992;29:791-793.
18. Duret RL, Bastenie PA. Intestinal disorders in hypothyroidism: clinical and manometric study. Am J Dig Dis. 1971;16:723-727.
19. Hohl RD, Nixon RK. Myxedema ileus. Arch Intern Med. 1965;115:145-150.
20. De Giorgio R, Barbara G, Stanghellini V, et al. Clinical and morphofunctional features of idiopathic myenteric ganglionitis underlying severe intestinal motor dysfunction: a study of three cases. Am J Gastroenterol. 2002;97:2454-2459.
21. Prata A. Chagas' disease. Infect Dis Clin North Am. 1994;8:61-76.
22. Schuffler MD, Rohrmann CA, Chaffee RG, Brand DL, Delaney JH, Young JH. Chronic intestinal pseudo-obstruction: a report of 27 cases and review of the literature. Medicine. 1981;60:173-196.
23. Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000;95:1456-1462.
24. von der Ohe MR, Camilleri M. Measurement of small bowel and colonic transit: indications and methods. Mayo Clin Proc. 1992;67:1169-1179.
25. Corazza GR, Sorge M, Strocchi A, et al. Non-absorbable antibiotics and small bowel bacterial overgrowth. Ital J Gastroenterol. 1992;24:4-9.
26. Debinski HS, Kamm MA, Talbot IC, Khan G, Kangro HO, Jeffries DJ. DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction. Gut. 1997;41:100-106.
27. Romagnuolo J, Schiller D, Bailey RJ. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol. 2002;97:1113-1126.
28. De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil. 2004;16:515-531.
29. De Giorgio R., Guerrini S, Barbara G, et al. Inflammatory neuropathies of the enteric nervous system. Gastroenterology. 2004;126:1872-1883.
30. Abell TL. Nutrition aspects of gastroparesis and therapies for drug-refractory patients. Nutr Clin Pract. 2006;21:23-33.
31. Scolapio JS, Ukleja A, Bouras EP, Romano M. Nutritional management of chronic intestinal pseudo-obstruction. J Clin Gastroenterol. 1999;28:306-312.
32. Allen JW, Ali A, Wo J, Bumpous JM, Cacchione RN. Totally laparoscopic feeding jejunostomy. Surg Endosc. 2002;16:1802-1805.
33. Tsuda K, Yokoyama Y, Morita M, Nakazawa Y, Onishi S. Selenium and chromium deficiency during long-term home PN in chronic idiopathic intestinal pseudoobstruction. Nutrition. 1998;14:291-295.
34. Buchman AL. Complications of long-term home PN: their identification, prevention and treatment. Dig Dis Sci. 2001;46:1-18.
35. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med. 1999;341:137-141.
36. Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991;325:1461-1467.
37. Murr MM, Sarr MG, Camilleri M. The surgeon's role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol. 1995;90:2147-2151.
38. Fishbein TM, Kaufman SS, Florman SS, et al. Isolated intestinal transplantation: proof of clinical efficacy. Transplantation. 2003;76:636-640.
39. Grant D, Abu-Elmagd K, Reyes J, et al. 2003 Report of the intestine transplant registry: a new era has dawned. Ann Surg. 2005;241:607-613.
40. Grant D. Intestinal transplantation: 1997 report of the international registry: Intestinal Transplant Registry. Transplantation. 1999;67:1061-1064.